Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CGMS advanced for three days, in 146 of 254 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for CGMS just turned positive on October 09, 2026. Looking at past instances where CGMS's MACD turned positive, the stock continued to rise in 17 of 37 cases over the following month. The odds of a continued upward trend are 46%.
The Aroon Indicator entered an Uptrend today. In 158 of 294 cases where CGMS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 19 of 52 cases where CGMS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 37%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CGMS as a result. In 24 of 64 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 38%.
CGMS moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CGMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 34%.
CGMS broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NFE declined for three days, in 314 of 343 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 48 cases where NFE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%.
NFE broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for NFE entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on NFE as a result. In 60 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for NFE just turned positive on October 13, 2026. Looking at past instances where NFE's MACD turned positive, the stock continued to rise in 30 of 39 cases over the following month. The odds of a continued upward trend are 77%.
Following a +34.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where NFE advanced for three days, in 214 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. NFE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.046) is normal, around the industry mean (147.140). P/E Ratio (-0.013) is within average values for comparable stocks, (6.511). Projected Growth (PEG Ratio) (22.725) is also within normal values, averaging (13.660). Dividend Yield (0.089) settles around the average of (15719315456.000) among similar stocks. P/S Ratio (0.056) is also within normal values, averaging (4.657).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NFE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 45, placing this stock worse than average.
NFE | ||
|---|---|---|
OUTLOOK RATING 1..100 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 92 | |
P/E GROWTH RATING 1..100 | 7 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CGMS | NFE | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 1 day ago 37% | 2 days ago 88% |
| Momentum ODDS (%) | 1 day ago 38% | 2 days ago 71% |
| MACD ODDS (%) | 2 days ago 46% | 2 days ago 77% |
| TrendWeek ODDS (%) | 1 day ago 33% | 2 days ago 90% |
| TrendMonth ODDS (%) | 1 day ago 54% | 2 days ago 90% |
| Advances ODDS (%) | 8 days ago 57% | 13 days ago 77% |
| Declines ODDS (%) | 6 days ago 34% | 2 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 38% | 2 days ago 83% |
| Aroon ODDS (%) | 1 day ago 54% | 2 days ago 90% |
A.I.dvisor indicates that over the last year, CGMS has been loosely correlated with DBD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CGMS jumps, then DBD could also see price increases.
| Ticker / NAME | Correlation To CGMS | 1D Price Change % | ||
|---|---|---|---|---|
| CGMS | 100% | +0.08% | ||
| DBD - CGMS | 35% Loosely correlated | -0.52% | ||
| NFE - CGMS | 6% Poorly correlated | -3.07% |
A.I.dvisor tells us that NFE and BIPC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NFE and BIPC's prices will move in lockstep.
| Ticker / NAME | Correlation To NFE | 1D Price Change % | ||
|---|---|---|---|---|
| NFE | 100% | -10.95% | ||
| BIPC - NFE | 32% Poorly correlated | -0.78% | ||
| OPAL - NFE | 27% Poorly correlated | -8.45% | ||
| SPH - NFE | 25% Poorly correlated | +2.55% | ||
| UGI - NFE | 24% Poorly correlated | +0.13% | ||
| NI - NFE | 23% Poorly correlated | +0.51% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CCFE | 26.19 | 0.29 | +1.13% |
| Concourse Capital Focused Equity ETF (CCFE) | |||
| RZG | 62.57 | 0.61 | +0.99% |
| Invesco S&P Smallcap 600 Pure Growth ETF (RZG) | |||
| BFJL | 18.66 | 0.12 | +0.62% |
| FT Vest Bitcoin Strategy Floor15 ETF - July | |||
| MXI | 109.60 | 0.39 | +0.36% |
| iShares Global Materials ETF (MXI) | |||
| FEOE | 56.03 | 0.04 | +0.07% |
| FIRST EAGLE OVERSEAS EQUITY ETF | |||